Dna X (SONM) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$4.3 million.
- Dna X's Enterprise Value rose 5228.48% to -$4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 5228.48%. This contributed to the annual value of -$8.0 million for FY2024, which is 1619.76% up from last year.
- According to the latest figures from Q3 2025, Dna X's Enterprise Value is -$4.3 million, which was up 5228.48% from -$5.4 million recorded in Q2 2025.
- In the past 5 years, Dna X's Enterprise Value registered a high of -$4.3 million during Q3 2025, and its lowest value of -$18.2 million during Q2 2022.
- Over the past 5 years, Dna X's median Enterprise Value value was -$9.6 million (recorded in 2024), while the average stood at -$10.0 million.
- In the last 5 years, Dna X's Enterprise Value surged by 8188.22% in 2021 and then tumbled by 16326.86% in 2022.
- Over the past 5 years, Dna X's Enterprise Value (Quarter) stood at -$12.3 million in 2021, then fell by 7.65% to -$13.2 million in 2022, then grew by 27.39% to -$9.6 million in 2023, then rose by 16.2% to -$8.0 million in 2024, then soared by 46.23% to -$4.3 million in 2025.
- Its last three reported values are -$4.3 million in Q3 2025, -$5.4 million for Q2 2025, and -$4.9 million during Q1 2025.